Cardinal gaining $700 mil. med/surg business via Bergen Brunswig acquisition.
This article was originally published in The Gray Sheet
Executive Summary
CARDINAL TO GAIN $700 MIL. MED/SURG BUSINESS VIA BERGEN BRUNSWIG BUY, for which a definitive merger agreement was announced Aug. 24. In addition to combining two drug distribution giants, the merger would greatly expand Cardinal's medical/surgical products business, which generates about $100 mil. in revenue. The deal is valued at $2.8 bil.